Publication | Open Access

A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial

Gastrointestinal OncologyMedicineColorectal CancerMetastatic Colorectal CancerBevacizumab AloneSurgeryPharmacotherapyCancer TreatmentOncologyRadiation OncologyNordic Act Trial